SRM Entertainment’s 400% Amazon Sales Increase and More

December 4, 2024

DENVER, Colo., Dec 04, 2024 (247marketnews.com)- Companies mentioned; SRM Entertainment (NASDAQ: SRM), Amazon (NASDAQ: AMZN), Cyclerion Therapeutics (NASDAQ: CYCN), Heron Therapeutics (NASDAQ: HRTX), Intuitive Machines (Nasdaq: LUNR), and VCI Global (NASDAQ: VCIG).

SRM Entertainment (NASDAQ: SRM) reported that its Amazon (NASDAQ: AMZN) sales increased over 417% since September, driven by strong customer demand for the company’s high-margin products and is expected to have a significant positive impact on its financial performance.

Rich Miller, SRM’s CXEO, stated, “Amazon offers a tremendous platform for us to reach our online customers. We have strategically leveraged data analytics to effectively target our customer base and drive online sales growth. This success underscores our commitment to expanding our e-commerce presence and maximizing profitability.

“Amazon has been an invaluable partner in our e-commerce success. They provide us with powerful tools and insights that enable us to optimize our product listings, reach the right customers, and efficiently manage our online operations. Their expertise in e-commerce logistics and fulfillment has been crucial in ensuring a seamless experience for our customers.”

SRM Entertainment ran better in the morning’s premarket, but trading halts may have killed the momentum. Keep an eye on it, because SRM may squeeze the shorts.

Cyclerion Therapeutics (NASDAQ: CYCN) is another squeezer that’s dealing with trading halts. MoBot originally posted this move Nov 15 at $2.068 and multiple times since, including this morning at $3.337, and it set a new 52-week high of $8.44 this morning.

The U.S. District Court for the District of Delaware ruled in favor of Heron Therapeutics (NASDAQ: HRTX) in its patent litigation against Fresenius Kabi USA with respect to CINVANTI (aprepitant) injectable emulsion. The court determined that Heron’s U.S. Patents, 9,561,229 and 9,974,794, are valid and would be infringed by Fresenius’ proposed generic product. Heron will now seek a Court order barring Fresenius from launching its generic CINVANTI until after the patents expire in 2035.

Craig Collard, Heron’s CEO, stated, “We are pleased with this anticipated result of the proceeding and will continue to vigorously defend the CINVANT patent estate in the future. The team at Heron takes great pride in the result of our successful history of developing injectable products, which is demonstrated by the strength of our intellectual property and the performance of our innovative drugs like CINVANTI in serving patients with serious unmet needs.”

Intuitive Machines (NASDAQ: LUNR) gapped down following its pricing of an upsized offering of 9,523,810 shares of its Class A common stock at $10.50 per share, but it’s been moving higher since the open and, if the momentum continues, may even turn green on the day.

VCI Global (NASDAQ: VCIG) is rebounding from the pullback that followed its huge gain  that resulted from last week’s news that its subsidiary, V-Gallant, received a conditional Letter of Award valued at approximately US$24 million from Hexatoff Group for its proposed data center project in Enstek City, Malaysia, in which V-Gallant was selected to supply AI hardware and software solutions, including an AI computing system featuring 640 units of NVIDIA H200 Tensor Core GPUs

Please go to 247marketnews.com to sign up for free MoBot alerts and view Mobot’s real time data.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (SRM, AMZN, CYCN, HRTX, LUNR, VCIG)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.